The FDA announced on March 5, 2024, that Randox Laboratories Ltd. is recalling Clinical Chemistry Calibration Serum (Catalog number Cal2351) due to negative bias in Inorganic Phosphate levels. The agency classified the recall as Class II.
How to tell if you have it
- Randox
- Clinical Chemistry Calibration Serum
- Cal2351
- 05055273200966
- Lot No. 1260UE, 1262UE, 1295UE, 1297UE, 1298UE, 1315UE, 1325UE, 1326UE, 1295UE, & 1325UE
- Nationwide Distribution
The hazard
Randox Laboratories has identified that Inorganic Phosphate in Calibration Serum Level 3, CAL2351 & CAL10388, is running with a negative bias on RX Series instruments compared to other methods.
Context
GovInfoNow's records show Randox Laboratories Ltd. has 49 other recalls on record since June 7, 2017. Other recent recalls include the Randox Cystatin C Reagent Recall (June 7, 2024), the Randox Evidence MultiSTAT Software v3.7 Recall (April 5, 2024), and the Randox Liquid Protein Calibrators Recall (March 1, 2024). Other recent recalls of similar products include the Siemens Dimension Tacrolimus Flex Reagent Cartridge Recall (May 7, 2026), the Siemens Dimension Creatinine Flex Reagent Cartridge Recall (March 18, 2026), and the Beckman Coulter Access Total T4 Calibrator Recall (March 16, 2026).